Novel Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?
NOVEL LABS INC has fifty-six approved drugs.
There are three tentative approvals on NOVEL LABS INC drugs.
Drugs and US Patents for Novel Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novel Labs Inc | MORPHINE SULFATE | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 203602-003 | Dec 16, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novel Labs Inc | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 209786-001 | Aug 29, 2018 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novel Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, CHEWABLE;ORAL | 204115-003 | Feb 25, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Novel Labs Inc | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | CAPSULE;ORAL | 204746-001 | Dec 30, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novel Labs Inc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 204330-002 | Mar 16, 2016 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novel Labs Inc | FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 206003-001 | Jul 21, 2017 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.